• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAbivax SA
    Picture of Abivax SA logo

    ABVX — Abivax SA News Story

    €81.950.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeLarge CapSucker Stock
    • Market Cap
      €6.54bn
    • Enterprise Value
      €6.13bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ABVX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ABVX Dividends
    All News

    NASDAQ RESUMED AT 04:30 PM

    Picture of Abivax SA logoAbivax SA
    01/06/2026 21:30
    NASDAQ RESUMED  AT 04:30 PM

    Recent news on Abivax SA

    See all news
    • Abivax shares fall after rival drug data, trader says

      Mon 12:47
    • France's Abivax H1 net loss widens on higher expenses driven by clinical programs

      21/09/2026 21:27
    • U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals

      10/09/2026 08:23
    • GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate

      10/09/2026 08:05
    • Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data

      07/08/2026 10:12

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.